Drawing for NANOSTRING

USPTO serial 86500106

NANOSTRING

Reviewed by CopyMark Law Group

Reg. 5147159Status 702Renewal
Filing date
Status date
Registration date
Feb 21, 2017
Examiner
MCCRAY, RENEE
Law office
TMO LAW OFFICE 111

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with NANOSTRING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Chidera N. Dawodu

Chidera N. Dawodu WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL RDPALO ALTO, CA 94304-1050UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples, detecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications, all being downloadableACTIVE—
010Clinical and medical diagnostic instruments, namely, nucleic acid sequencersACTIVE—
042Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiring, analyzing and managing biological and genetic information, in the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicine, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes, and industrial quality control processes; developing systems for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes, environmental and testing processes and industrial quality control processes; chemical screening analysis for othersACTIVEAug 16, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 21, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 4, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 13, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 13, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 13, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 18, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Feb 21, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 18, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 21, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 20, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 19, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 19, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 9, 2016IUAFUSE AMENDMENT FILED—
Sep 9, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 8, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 7, 2016EX2GSOU EXTENSION 2 GRANTED—
Sep 7, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 11, 2016EXT2SOU EXTENSION 2 FILED—
Aug 11, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 9, 2016EX1GSOU EXTENSION 1 GRANTED—
Feb 9, 2016EXT1SOU EXTENSION 1 FILED—
Feb 9, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 11, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 16, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 12, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 12, 2015ALIEASSIGNED TO LIE—
Apr 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Apr 20, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 20, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 20, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 15, 2015DOCKASSIGNED TO EXAMINER—
Jan 23, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jan 22, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 13, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance